Search Results

Serimmune will discuss its Serum Epitope Repertoire Analysis (SERA) platform and how it can be applied in various studies to gain insight into past and present humoral immune responses in individuals and cohorts.

Serimmune, a leader in understanding the antibody repertoire’s role in human disease, announced today the appointment of Gary Schroth, PhD, Vice President and Distinguished Scientist at Illumina, to its Scientific Advisory Board (SAB).

Serimmune announced today the publication of a study in Nature in which their proprietary Serum Epitope Repertoire Analysis (SERA) technology platform was one of the methods used to analyze the biological processes associated with the development and persistence of Long COVID symptoms, such as fatigue, brain fog and malaise.

The U.S. Department of Health and Human Services and the Cohen Foundation have selected Serimmune as a Phase 1 winner in the LymeX Diagnostics Prize, a LymeX Innovation Accelerator (LymeX) prize competition to accelerate the development of Lyme disease diagnostics.

Serimmune, Inc., a leader in understanding the functional antibody repertoire’s role in human disease, announced today that the company is enrolling 2,000 research participants in a study designed to understand the human immune response to SARS-CoV-2, the virus that causes COVID-19

Serimmune, a leader in understanding the antibody repertoire’s role in human disease, and Mymee, a leading provider of digital care programs for reducing persistent symptoms resulting from autoimmune disease, chronic inflammation and long haul COVID, announced today that they will collaborate on a clinical research study to describe the role antibodies play in patients suffering from COVID-19.

Serimmune to apply its SERA technology to identify the targets of Atreca therapeutic antibody candidates

Serimmune announced that the company has received a research milestone payment from Merck under its ongoing discovery and development collaboration agreement.

Serimmune to map epitopes of current Twist antibodies - Twist to use epitopes to re-screen Twist libraries to identify & evaluate novel candidates

Better understand the B-cell response to SARS-CoV-2 infection and vaccination with high-resolution antibody epitope mapping across the entire SARS-CoV-2 proteome